Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,764,066
-$590,151 QoQ
Shares Held
21,878
-9.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#734
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGESPRING WEALTH PARTNERS, LLC holds $61,133,825 across 14 Drug Manufacturers - General names. GILD ranks #6 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,000 | $13,193,731 | |
| 2 | JNJ |
Johnson & Johnson
|
46,596 | $11,833,986 | |
| 3 | ABBV |
AbbVie Inc.
|
39,038 | $9,823,522 | |
| 4 | MRK |
Merck & Co., Inc.
|
67,467 | $8,669,509 | |
| 5 | AMGN |
Amgen Inc
|
18,256 | $6,610,862 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
21,878 | $2,764,066 | |
| 7 | NVS |
Novartis AG
|
10,590 | $1,659,664 | |
| 8 | AZN |
Astrazeneca PLC
|
8,616 | $1,633,765 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,764,066 | 21,878 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,354,217 | 24,067 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,816,269 | 22,945 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,152,290 | 19,390 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,923,705 | 17,351 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,513,011 | 13,503 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,102,897 | 11,940 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||